Recent Finacing
Recent Raise
Sherlock Biosciences develops CRISPR-based SHERLOCK and synthetic-biology INSPECTR platforms for instrument-free, room-temperature nucleic-acid detection, delivering paper-strip, electrochemical, and mobile-readable tests for at-home, POC, and lab use.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
